56921
Strep B ChromoSelect Selective Agar Base
suitable for microbiology, NutriSelect® Plus
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Code UNSPSC :
41171606
Nomenclature NACRES :
NA.85
Produits recommandés
Stérilité
non-sterile
Niveau de qualité
Forme
powder
Durée de conservation
limited shelf life, expiry date on the label
Composition
agar, 15.0 g/L
buffers, 2.5 g/L
chromogenic mixture, 2.54 g/L
protein hydrolysate, 17.5 g/L
selective agents, 0.110 g/L
Fabricant/nom de marque
NutriSelect® Plus
pH final
7.3±0.2 (25 °C)
Application(s)
clinical testing
veterinary
microbiology
Température de stockage
2-8°C
Adéquation
Streptococcus spp.
Application
Strep B ChromoSelect Selective Agar Base is recommended for selective isolation of Group B streptococci.
Notes préparatoires
Suspend 37.65 grams in 1000 ml distilled water. Heat to boiling to dissolve the medium completely. DO NOT AUTOCLAVE. Cool to 45-50°C and aseptically add the rehydrated contents of one vial of Strep B ChromoSelect Selective Supplement (Cat. No. 92650). Mix well and pour in sterile Petri plates.
Note de bas de page
We offer two media types: the superior granulated GranuCult® and the cost-efficient powdered NutriSelect® culture media, depending on your needs.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.
Informations légales
GRANUCULT is a registered trademark of Merck KGaA, Darmstadt, Germany
NutriSelect is a registered trademark of Merck KGaA, Darmstadt, Germany
Code de la classe de stockage
13 - Non Combustible Solids
Classe de danger pour l'eau (WGK)
WGK 2
Point d'éclair (°F)
Not applicable
Point d'éclair (°C)
Not applicable
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Murray, P.R., E.J. Baron, J.H. Jorgensen, M.A. Pfaller, and R. H. Yolken (Eds.)
Manual of Clinical Microbiology (2003)
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 45(RR-7), 1-24 (1996-05-31)
Group B streptococcus is a leading cause of serious neonatal infection. Most neonatal GBS infections can be prevented through the use of intrapartum antimicrobial prophylaxis in women who are at increased risk for transmitting the infection to their newborns. However
B F Anthony et al.
The Journal of infectious diseases, 137(5), 524-530 (1978-05-01)
A longitudinal, three-year study of the epidemiology of group B Streptococcus was conducted with repeated (four to 11) observations of 382 patients followed through pregnancy, delivery, and the postpartum period. Group B streptococci (2.3% of which were nonhemolytic) were isolated
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique